title: Effects of acute administration of ketorolac on mammalian vestibular sensory evoked potentials.
abstract: The nonsteroidal antiinflammatory drug (NSAID) ketorolac is a candidate for use as a supplemental analgesic during major surgery in anesthetized rodents. The use of ketorolac during surgery is believed to reduce the anesthetic dose required to achieve and maintain an adequate surgical plane, thus improving the physiologic condition and survival of animals during long experimental procedures. Ketorolac has reported side effects that include dizziness, ear pain, hearing loss, tinnitus, and vertigo in humans, but ketorolac has not been reported to affect the vestibular system in animals. To investigate this possibility, we evaluated the acute effects of ketorolac on vestibular compound action potentials in C57BL/6 mice. Linear vestibular sensory-evoked potentials (VsEP) were recorded during the administration of ketorolac at doses 3 to 14 times the effective analgesic dose. VsEP results for ketorolac were compared with those from a control group maintained under anesthesia for the same period. Ketorolac did not significantly affect the temporal profiles of response latencies and amplitudes or the rate of change in response measures over time between controls and ketorolac-treated mice. These findings demonstrate that ketorolac can be used as an analgesic to supplement anesthesia in mice without concerns of modifying the amplitudes and latencies of the linear VsEP.
authors.affiliation: Department of Communication Sciences and Disorders, East Carolina University, Greenville, North Carolina, USA.
authors.forename: G Christopher
authors.initials: GC
authors.lastname: Gaines
authors.forename: Timothy A
authors.initials: TA
authors.lastname: Jones
mesh_terms: D000698:Analgesia / Q000662:veterinary*; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology; D020910:Ketorolac / Q000494:pharmacology*; D016014:Linear Models; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D058585:Vestibular Evoked Myogenic Potentials / Q000187:drug effects*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D020910:Ketorolac
references.citation: J Emerg Med. 1995 Jul-Aug;13(4):509-13
references.pmid: 7594371
references.citation: J Pharmacol Exp Ther. 1999 Mar;288(3):1288-97
references.pmid: 10027870
references.citation: Hear Res. 1999 Sep;135(1-2):56-60
references.pmid: 10491954
references.citation: Hear Res. 2011 Oct;280(1-2):133-40
references.pmid: 21664446
references.citation: Clin Exp Pharmacol Physiol. 1998 Dec;25(12):1032-7
references.pmid: 9888002
references.citation: Clin Nephrol. 1997 Mar;47(3):208-9
references.pmid: 9105776
references.citation: J Neurosci Methods. 2002 Jul 30;118(1):23-31
references.pmid: 12191754
references.citation: Electroencephalogr Clin Neurophysiol. 1992 May;82(5):377-86
references.pmid: 1374706
references.citation: Hear Res. 1999 Oct;136(1-2):75-85
references.pmid: 10511626
references.citation: J Vestib Res. 1998 May-Jun;8(3):253-72
references.pmid: 9626651
references.citation: Eur J Pharmacol. 1990 Feb 27;177(3):127-35
references.pmid: 2311674
references.citation: J Vestib Res. 1998 May-Jun;8(3):233-52
references.pmid: 9626650
references.citation: Drug Metab Dispos. 1987 Sep-Oct;15(5):618-26
references.pmid: 2891477
references.citation: Drug Saf. 2000 Jun;22(6):487-97
references.pmid: 10877042
references.citation: J Infect Dis. 1999 Jan;179(1):264-8
references.pmid: 9841852
references.citation: Agents Actions. 1982 Dec;12(5-6):684-90
references.pmid: 6984594
references.citation: J Assoc Res Otolaryngol. 2011 Apr;12(2):173-83
references.pmid: 21052761
references.citation: J Vet Pharmacol Ther. 1999 Oct;22(5):314-9
references.pmid: 10597535
references.citation: Drugs Exp Clin Res. 1985;11(8):479-92
references.pmid: 3879752